Title:
METHOD FOR ANTI-MUC1* CAR T CELL STIMULATION
Document Type and Number:
WIPO Patent Application WO/2019/173815
Kind Code:
A3
Abstract:
The present application discloses a composition comprising a MUC1* extra cellular domain peptide attached to a surface and an immune cell that bears a receptor that binds to the peptide.
Inventors:
BAMDAD CYNTHIA (US)
GLENNIE NELSON (US)
GLENNIE NELSON (US)
Application Number:
PCT/US2019/021556
Publication Date:
October 17, 2019
Filing Date:
March 11, 2019
Export Citation:
Assignee:
MINERVA BIOTECHNOLOGIES CORP (US)
International Classes:
C07K16/18; A61K49/16; A61P35/04; C07K16/30; C07K16/32; C07K16/40
Domestic Patent References:
| WO2016130726A1 | 2016-08-18 | |||
| WO2018071583A2 | 2018-04-19 |
Other References:
WANG, X ET AL.: "Clinical manufacturing of CAR T cells: foundation of a promising therapy", MOLECULAR THERAPY ONCOLYTICS, vol. 3, 15 June 2016 (2016-06-15), pages 16015, XP055396211
Attorney, Agent or Firm:
KIM, Joseph, Hyosuk (US)
Download PDF:
Previous Patent: PROTECTIVE GROUPS AND METHODS FOR PROTECTING BENZOXABOROLES OR OXABOROLES
Next Patent: ILLUMINATION APPARATUS
Next Patent: ILLUMINATION APPARATUS